Letter to the Editor: Alzheimer's Disease-Associated APOE ε4 Frequencies in Indian Population Genomes May Suggest Implications in Lecanemab Treatment

J Prev Alzheimers Dis. 2024;11(2):525-526. doi: 10.14283/jpad.2023.122.
No abstract available

MeSH terms

  • Alzheimer Disease* / drug therapy
  • Alzheimer Disease* / epidemiology
  • Alzheimer Disease* / genetics
  • Antibodies, Monoclonal, Humanized*
  • Apolipoprotein E4 / genetics
  • Apolipoproteins E
  • Humans
  • Neuropsychological Tests

Substances

  • Apolipoprotein E4
  • lecanemab
  • Apolipoproteins E
  • Antibodies, Monoclonal, Humanized